Belluscura Past Earnings Performance
Past criteria checks 0/6
Belluscura's earnings have been declining at an average annual rate of -38.5%, while the Medical Equipment industry saw earnings growing at 2% annually. Revenues have been growing at an average rate of 22.5% per year.
Key information
-38.5%
Earnings growth rate
-16.5%
EPS growth rate
| Medical Equipment Industry Growth | 4.3% |
| Revenue growth rate | 22.5% |
| Return on equity | -39.7% |
| Net Margin | -831.7% |
| Last Earnings Update | 30 Jun 2023 |
Recent past performance updates
Recent updates
Revenue & Expenses BreakdownBeta
How Belluscura makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 23 | 1 | -10 | 6 | 0 |
| 31 Mar 23 | 1 | -9 | 6 | 0 |
| 31 Dec 22 | 1 | -8 | 7 | 0 |
| 30 Sep 22 | 1 | -8 | 7 | 0 |
| 30 Jun 22 | 1 | -7 | 8 | 0 |
| 31 Mar 22 | 1 | -6 | 6 | 0 |
| 31 Dec 21 | 0 | -5 | 5 | 0 |
| 30 Sep 21 | 0 | -5 | 4 | 0 |
| 30 Jun 21 | 0 | -4 | 3 | 0 |
| 31 Mar 21 | 0 | -3 | 2 | 0 |
| 31 Dec 20 | 0 | -2 | 1 | 0 |
| 31 Dec 19 | 0 | -2 | 1 | 0 |
| 31 Dec 18 | 0 | -1 | 1 | 0 |
| 31 Dec 17 | 0 | -3 | 3 | 0 |
| 30 Nov 16 | 0 | -1 | 1 | 0 |
Quality Earnings: 9VQ is currently unprofitable.
Growing Profit Margin: 9VQ is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 9VQ is unprofitable, and losses have increased over the past 5 years at a rate of 38.5% per year.
Accelerating Growth: Unable to compare 9VQ's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 9VQ is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (-9.8%).
Return on Equity
High ROE: 9VQ has a negative Return on Equity (-39.69%), as it is currently unprofitable.